(Q52488997)

2 May 2018

title

Complement-derived polypeptide C3adesArg as a mediator of inflammation at the blood-brain barrier in a new experimental cat model. (English)

1 reference

2 May 2018

0 references

1 reference

H G Höllerhage

1

1 reference

2 May 2018

G F Walter

series ordinal

2

1 reference

2 May 2018

D Stolke

series ordinal

3

1 reference

2 May 2018

publication date

1 January 1989

1 reference

2 May 2018

published in

Acta Neuropathologica

1 reference

2 May 2018

volume

77

1 reference

2 May 2018

issue

3

1 reference

2 May 2018

page(s)

307-313

1 reference

2 May 2018

Cerebrovascular actions of prostaglandins

cites work

1 reference

12 December 2020

The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement

1 reference

12 December 2020

Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis

1 reference

12 December 2020

Pharmacokinetic aspects of cerebrospinal fluid penetration of fosfomycin

1 reference

12 December 2020

Interaction of the clotting, kinin-forming, complement, and fibrinolytic pathways in inflammation

1 reference

12 December 2020

Complement-derived leukotactic factors in pathological fluids

1 reference

12 December 2020

Activation of the complement system

1 reference

12 December 2020

Contribution of complement factors and reaction pathways to inflammation.

1 reference

12 December 2020

Effects of vasospasm on levels of prostacyclin and thromboxane A2 in cerebral arteries of the monkey

1 reference

12 December 2020

Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes

1 reference

12 December 2020

Purification and partial amino acid sequence of classical anaphylatoxin from pig serum: identification with Des-Arg-C5a

1 reference

12 December 2020

Carrageenan-induced brain inflammation. Characterization of the model

1 reference

12 December 2020

Measurement of prostaglandins in the cerebrospinal fluid in cat, dog, and man.

1 reference

12 December 2020

Structure and function of the anaphylatoxins

1 reference

12 December 2020

Tobramycin Levels in Cerebrospinal Fluid of Patients with Slightly and Severely Impaired Blood-Cerebrospinal Barrier

1 reference

12 December 2020

The Role of Prostaglandins in the Central Nervous System

1 reference

12 December 2020

Biological activities of C5a and C5adesArg from hog serum.

1 reference

12 December 2020

Cerebrospinal fluid immunoglobulins and complement in meningococcal meningitis

1 reference

12 December 2020

Ampicillin in the treatment of acute suppurative meningitis

1 reference

12 December 2020

Effects of the cleavage peptides, C3q and C3ai, from the third component of hog complement on leukocyte accumulation and vascular permeability in vivo.

1 reference

12 December 2020

The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.

1 reference

12 December 2020

Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation

1 reference

12 December 2020

Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis

1 reference

12 December 2020

Alterations of complement components in disease

1 reference

12 December 2020

Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis

1 reference

12 December 2020

Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space

1 reference

12 December 2020

The role of complement in experimental disease models

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00687583

1 reference

2 May 2018

1 reference

2 May 2018